Connect with us

Health

Beer, wine or liquor? Massive study reveals which was linked to lower death risk

Published

on

Beer, wine or liquor? Massive study reveals which was linked to lower death risk

NEWYou can now listen to Fox News articles!

Heavy drinking has been shown to raise mortality risk, but, at lower levels, what’s in your glass may also matter, a new study suggests.

In recent research of data from 340,924 participants in the UK Biobank, wine was linked to lower mortality, while beer and spirits were tied to higher death risk.

Data were collected between 2006 and 2022, with more than 13 years of average follow-up. The findings were presented at the American College of Cardiology’s Annual Scientific Session in New Orleans.

Advertisement

WINE EXPERT SAYS ONE COMMON HABIT COULD BE SABOTAGING EVERY SIP

In the study, participants reported their alcohol intake as never/occasional, low, moderate or high.

High consumption was defined as more than 40 grams per day for men (about three standard drinks) and more than 20 grams per day for women (about 1.4 standard drinks).

Heavy drinking has been shown to raise mortality risk, but, at lower levels, what’s in your glass may also matter, a new study suggests. (iStock)

Participants with high alcohol consumption had a 24% higher risk of all-cause death, 36% higher risk of cancer death and 14% higher risk of cardiovascular death when compared to people who never or occasionally drank, according to the study findings.

Advertisement

With low or moderate alcohol consumption, however, the mortality risk appeared to differ according to the type of beverage.

AMERICA HITS MAJOR MARIJUANA MILESTONE AS DAILY WEED USE SURPASSES DAILY DRINKING

Spirits, beer and cider were associated with significantly higher mortality, the researchers found, while the same amount of wine intake was linked to significantly lower mortality. Moderate wine drinkers had a 21% lower risk of cardiovascular death than those who never or occasionally drank.

Conversely, those who drank low amounts of spirits, beer or cider were found to have a 9% higher risk of cardiovascular death.

In new research of data from 340,924 participants in the UK Biobank, wine was linked to lower mortality, while beer and spirits were tied to higher death risk. (iStock)

Advertisement

“These results come from the general population, and in certain high-risk groups, such as people with chronic diseases or cardiovascular conditions, the risks could be even higher,” Dr. Zhangling Chen, a professor at the Second Xiangya Hospital, Central South University in China and the study’s senior author, said in a press release.

“These findings can help refine guidance, emphasizing that the health risks of alcohol depend not only on the amount of alcohol consumed but also on the type of beverage.”

“Not everybody should have daily consumption of an alcoholic substance, whether it’s wine, beer or certain liquors.”

One potential reason for wine’s lower mortality association could be that it contains compounds such as polyphenols and antioxidants, which could have beneficial effects on blood vessels, inflammation and cardiovascular health, the researchers noted.

Jessica Steinman, a Los Angeles addiction specialist and chief clinical officer for No Matter What Recovery, said the study’s information is “helpful” but cautioned against broadly applying the findings to individuals, particularly those with a history of substance misuse.

Advertisement

HOME COCKTAIL MAKER SAYS GEN Z ISN’T GIVING UP ALCOHOL — THEY’RE CHANGING HOW THEY DRINK

While certain ingredients or substances might help someone with a specific issue, she expressed her concern when it comes to mental health issues and addiction.

“When we hear these stories or get this research, it becomes a ‘black and white’ larger generalization for the population, and we want to be careful with that,” Steinman, who was not involved in the research, told Fox News Digital.

Different substances have different levels of alcohol in them, and each person metabolizes alcohol differently, the expert noted. (iStock)

“Not everybody should have daily consumption of an alcoholic substance, whether it’s wine, beer or certain liquors. … If there’s someone who’s struggling with substances, then they really shouldn’t be having it at all.”

Advertisement

Different substances have different levels of alcohol in them, and each person metabolizes alcohol uniquely, the expert noted.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“All those kinds of things are so specific to one person or a small sect of people,” she said. “So, we want to make sure anytime there’s research given about something, that we’re not taking it as a society and saying, ‘Let’s do this,’ and not keeping it as black and white.

CLICK HERE FOR MORE HEALTH STORIES

“Overall, more is not better, but also the higher potency of alcohol and higher percentages of alcohol is going to affect people negatively as well.”

Advertisement

Steinman recommended consulting with a medical professional for individual guidance.

There was the chance that wine drinkers may have different dietary or other lifestyle habits that could impact their health outcomes, the researchers noted. (iStock)

The researchers acknowledged some limitations of the study. Because it was observational in design, the study could not prove that drinking wine led to lower mortality or that other alcoholic beverages directly caused higher mortality.

Also, the participants reported their baseline alcohol intake at the start of the study, which means any changes in drinking patterns during the follow-up period were not recorded.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

There was also the chance that wine drinkers may have different dietary or other lifestyle habits that could affect their health outcomes, the researchers noted.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

The UK Biobank participants also tend to be healthier than the overall population, which could limit the ability for the finding to be generalized to wider populations.

The authors called for high-quality randomized studies to confirm the differences in how drinking habits reflect mortality risk.

Advertisement

Health

Common cholesterol drug linked to lower dementia risk when started early

Published

on

Common cholesterol drug linked to lower dementia risk when started early

NEWYou can now listen to Fox News articles!

Starting statin therapy shortly after a type 2 diabetes diagnosis may not only protect the heart — it may also be linked to a lower dementia risk.

A large study presented at the European Society of Cardiology Congress in Munich on Aug. 30 found that adults who began taking a statin within one year of their type 2 diabetes diagnosis had a 15% lower relative risk of developing dementia over 10 years compared to those who did not take the medication within five years.

Even for those who delayed starting a statin for one to five years, there was still a 10% lower relative risk, according to the findings, which were published in The Lancet Regional Health – Europe.

Advertisement

3 THINGS TO AVOID IN MIDDLE AGE COULD MEAN 13 MORE YEARS WITHOUT DEMENTIA, STUDY FINDS

A statin is a prescription medication that lowers “bad” LDL cholesterol and helps reduce the risk of heart attack and stroke.

Researchers conducted the study by tracking health data from 132,585 patients in Denmark who were diagnosed with type 2 diabetes between 2006 and 2019 and had no prior history of statin use or dementia.

A statin is a prescription medication that lowers “bad” LDL cholesterol and helps reduce the risk of heart attack and stroke. (iStock)

During a median follow-up of 7.1 years, the team analyzed how the timing of statin treatment impacted overall dementia rates.

Advertisement

Dr. Liron Sinvani, a geriatrician and director for research and innovation at the Northwell Institute for Healthy Aging in New York, said this was a “well-designed, large-scale observational study that adds to a growing body of evidence suggesting that statins may help protect brain health.”

GAME-CHANGING CHOLESTEROL PILL WINS FDA APPROVAL AFTER CUTTING LDL NEARLY 60%

She noted that while a 15% reduction is a modest improvement, it remains “very significant.”

People with type 2 diabetes have an increased risk of cognitive decline and heart disease, consistent with previous research.

Starting a statin within one year of a type 2 diabetes diagnosis was associated with a 15% lower relative risk of developing dementia over 10 years, while delaying treatment reduced the benefit to 10%. (iStock)

Advertisement

Although guidelines generally recommend statins for many adults ages 40 to 75 with diabetes, statin treatment is not always started soon after a type 2 diabetes diagnosis.

The study also examined whether the timing of treatment was linked to dementia risk. People who started statins within a year of their diagnosis had a lower risk than those who did not begin treatment.

CLICK HERE FOR MORE HEALTH STORIES

“The message here is that maybe waiting is actually not the right approach,” Sinvani said, supporting earlier consideration of statin therapy in routine diabetes care.

The expert said she found the results “especially compelling” because the benefit was driven by a lower risk of vascular dementia rather than Alzheimer’s disease.

Advertisement

“The message here is that maybe waiting is actually not the right approach.”

“And that makes biological sense, because we know statins lower cholesterol, reduces inflammation and protects blood vessels,” she added, pointing out that these same mechanisms prevent vascular damage to the brain.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Statin therapy should be viewed as one piece of a broader health strategy alongside exercising regularly, adhering to a healthy diet and staying socially connected, according to the expert.

Because this was an observational study rather than a randomized controlled trial, the findings show a strong association but do not prove a direct causal link. (iStock)

Advertisement

Almost half of dementia cases may be preventable or delayable by addressing modifiable risk factors, according to the Lancet Commission.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The study did have limitations. Because it was observational rather than a randomized clinical trial, the researchers could not definitively state that statins directly prevent dementia.

As Sinvani cautioned, “This is not proof that statins prevent dementia, but I think it’s an important step in this literature.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Advertisement

The doctor encouraged people with type 2 diabetes who are not taking a statin to ask their doctor whether the medication is appropriate for them.”

Advertisement
Continue Reading

Health

Marijuana users may face hidden driving danger that standard tests can miss

Published

on

Marijuana users may face hidden driving danger that standard tests can miss

NEWYou can now listen to Fox News articles!

A new study warns that driving after eating cannabis edibles can significantly impair road performance and reaction times, even if blood tests show THC levels far below the legal limit.

The findings, published in JAMA Network Open, highlight a potential challenge for impaired-driving enforcement in Canada and some U.S. jurisdictions.

Most previous cannabis-driving studies have involved smoked or inhaled marijuana, which more rapidly spikes levels of THC (tetrahydrocannabinol, the main psychoactive compound in cannabis) in the bloodstream.

Advertisement

AMERICA HITS MAJOR MARIJUANA MILESTONE AS DAILY WEED USE SURPASSES DAILY DRINKING

Edibles are absorbed more slowly and can produce driving impairment even when blood THC concentrations remain relatively low.

Researchers found that drivers who consumed higher doses of edible THC struggled with lane control, had slower reaction times and experienced greater speed fluctuations. Yet, their blood tests stayed below the standard legal cutoff used to prove impairment at roadside traffic stops.

Researchers measured how well drivers stayed in their lane, how quickly they reacted to road events and how consistently they maintained their speed. (iStock)

To assess how oral cannabis impacts driving, researchers at the Centre for Addiction and Mental Health in Toronto conducted a trial with 40 healthy adult volunteers who regularly use cannabis.

Advertisement

Each participant attended four separate sessions in which they consumed soft-chew gummies containing either 0, 2, 10 or 20 milligrams of THC.

CANNABIS COMPOUNDS COULD REVERSE DISEASE AFFECTING ONE-THIRD OF ADULTS

The researchers then tested the drivers using a driving simulator at two, five and 24 hours after consumption, tracking how well drivers stayed in their lane, how quickly they reacted to road events and how consistently they maintained their speed.

Blood samples and self-reported ratings of intoxication were also collected.

Participants recognized their own limitations, reporting a lower willingness to drive and reduced confidence in their driving skills after taking the gummies. (iStock)

Advertisement

The results showed driving impairment at two and five hours after consuming 10- and 20-milligram gummies. Compared with placebo, participants who consumed those doses had greater variability in lane position, while the 20-milligram dose was also linked to slower reaction times and less consistent speed control.

Participants also recognized their own limitations, reporting a lower willingness to drive and reduced confidence in their driving skills after taking the gummies.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

The highest blood THC concentrations averaged 1.6 nanograms per milliliter after the 10-milligram dose and 3.4 nanograms per milliliter after the 20-milligram dose. Those levels were below the commonly used 5-ng/mL threshold, although THC limits vary by jurisdiction and some individual samples exceeded 5 ng/mL.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

By comparison, participants in the team’s previous smoked-cannabis study showed similar levels of impairment while reaching an average peak blood THC concentration of 30.3 nanograms per milliliter, nearly 10 times higher than the 20-milligram edible group.

The study did have some limitations. Tests were conducted on virtual simulators rather than actual roads, meaning drivers faced no real physical risk during the experiments. It also focused on regular cannabis users, so it is unclear how occasional users might react to similar doses.

When the research team previously tested smoked marijuana, drivers with similar impairment levels registered blood THC concentrations averaging 30.3 nanograms per milliliter, nearly 10 times higher. (iStock)

Additionally, minimal residual effects were detected after 24 hours. While maximum speed remained slightly higher among participants on the 10-milligram and 20-milligram doses, subjective feelings of intoxication had completely faded.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

In an accompanying commentary, Dr. José Ignacio Nazif-Munoz of the Université de Sherbrooke noted that these biological differences pose a challenge for law enforcement.

CLICK HERE FOR MORE HEALTH STORIES

Because edibles are absorbed slowly through the digestive system, standard blood tests may fail to identify unsafe drivers, leaving policymakers searching for more reliable roadside tools.

“The delayed absorption and prolonged duration of effects of edible cannabis distinguish it from smoked or inhaled cannabis, complicating the interpretation of biological measures,” he wrote.

Advertisement

Continue Reading

Health

Walking for Weight Loss? These Surprising Tips Boost Fat Burn Fast

Published

on

Walking for Weight Loss? These Surprising Tips Boost Fat Burn Fast


Advertisement





How Walking for Weight Loss Helps Burn More Fat After 50



















Advertisement



Advertisement




Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Advertisement
Continue Reading
Advertisement

Trending